- Regulatory and clinical setbacks for some late-stage potential medicines.
- Need to increase diversity in clinical trials.
Cytokinetics, Inc.
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, Cytokinetics, Inc. disclosed greenhouse gas emissions of 1.2K metric kilotons CO2e. By scope: Scope 1: 391 metric kilotons CO2e; Scope 2: 839 metric kilotons CO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
1.2K metric kilotons CO2e
2023
Renewable Energy
Nearly 50%
of total energy
Water Usage
1.488 million gallons
2023
Waste
87.60 tons (non-hazardous); 18.36 tons (hazardous)
2023
Energy Use
4.5K MWh
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 391 metric kilotons CO2e |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 839 metric kilotons CO2e |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023 | 1.2K metric kilotons CO2e |
| 2022 | 1.50 metric kilotons CO2e |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Scope 1 and 2 GHG emissions decreased by 20% compared to 2022
- Achieved nearly 50% renewable electricity use in Cytokinetics facilities
- Launched a new office waste management program aiming to reduce landfill waste by up to 75%.
🎯 Climate & Sustainability Targets
🔜 Short-term
- Reduce landfill waste by up to 75% over the next few years.
🌱 ESG Focus Areas
Patient CentricityDiversity, Equity, Inclusion, and RespectEnvironmental SustainabilityCommunity Engagement